These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8326526)
21. [Study about proliferation and apoptosis of megakaryocytes in patients with myelodysplastic syndromes]. Li X; Pu Q; Liu YZ; Shi J; Tao Y; Chang CK; Jiang QY; Huang W Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):40-3. PubMed ID: 12513835 [TBL] [Abstract][Full Text] [Related]
22. Expression of the multidrug resistance P-glycoprotein and its relationship to hematological characteristics and response to treatment in myelodysplastic syndromes. Lepelley P; Soenen V; Preudhomme C; Lai JL; Cosson A; Fenaux P Leukemia; 1994 Jun; 8(6):998-1004. PubMed ID: 7516032 [TBL] [Abstract][Full Text] [Related]
23. [Expression of a proliferation associated-nuclear antigen defined by Ki-67 monoclonal antibody in childhood acute leukemia]. Ito M; Tsurusawa M; Kawai S; Fujimoto T Rinsho Ketsueki; 1995 Aug; 36(8):713-9. PubMed ID: 7563603 [TBL] [Abstract][Full Text] [Related]
24. A quantitative evaluation of erythropoiesis in myelodysplastic syndromes using multiparameter flow cytometry. Jensen IM; Hokland M; Hokland P Leuk Res; 1993 Oct; 17(10):839-46. PubMed ID: 8412296 [TBL] [Abstract][Full Text] [Related]
25. [Abnormalities of CD34+ cells differentiation and bone marrow cell cycle in myelodysplastic syndrome]. Li LJ; Fu R; Shao ZH; Wang HQ; Yue LZ; Ruan EB; Liu H; Wang J; Wang HL Zhonghua Nei Ke Za Zhi; 2010 Nov; 49(11):963-6. PubMed ID: 21211213 [TBL] [Abstract][Full Text] [Related]
26. Determination of proliferative activities in human brain tumor specimens: a comparison of three methods. Morimura T; Kitz K; Stein H; Budka H J Neurooncol; 1991 Feb; 10(1):1-11. PubMed ID: 2022970 [TBL] [Abstract][Full Text] [Related]
27. Megakaryocytopoiesis and apoptosis in patients with myelodysplastic syndromes. Li X; Pu Q Leuk Lymphoma; 2005 Mar; 46(3):387-91. PubMed ID: 15621828 [TBL] [Abstract][Full Text] [Related]
28. Expression of myeloid differentiation antigens on myeloblasts in bone marrow of patients with myelodysplastic syndromes. Borbenyi Z; Ghosh A; Cinkotai K; Balogh E; Moore M Biomed Pharmacother; 1987; 41(2):101-4. PubMed ID: 3475134 [TBL] [Abstract][Full Text] [Related]
29. Determination of the growth fraction in monoclonal gammopathy with the monoclonal antibody Ki-67. Lokhorst HM; Boom SE; Terpstra W; Roholl P; Gerdes J; Bast BJ Br J Haematol; 1988 Aug; 69(4):477-81. PubMed ID: 3044442 [TBL] [Abstract][Full Text] [Related]
30. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts]. Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026 [TBL] [Abstract][Full Text] [Related]
31. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors. Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245 [TBL] [Abstract][Full Text] [Related]
32. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes. Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438 [TBL] [Abstract][Full Text] [Related]
33. Limited numbers of apoptotic cells in fresh paraffin embedded bone marrow samples of patients with myelodysplastic syndrome. Brada SJ; van de Loosdrecht AA; Koudstaal J; de Wolf JT; Vellenga E Leuk Res; 2004 Sep; 28(9):921-5. PubMed ID: 15234568 [TBL] [Abstract][Full Text] [Related]
34. CD34 immunohistochemical staining of bone marrow biopsies in myelodysplastic syndromes. Min YH; Lee ST; Min DW; Kim TS; Lee CH; Lee BK; Hahn JS; Ko YW Yonsei Med J; 1995 Mar; 36(1):1-8. PubMed ID: 7537931 [TBL] [Abstract][Full Text] [Related]
36. [Relationship between macrophages and apoptosis in patients with myelodysplastic syndromes]. Li X; Ying SX; Liu YZ; Tao Y; Chang CK; Jiang QY; Huang W; Shi J; Pu Q Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):226-9. PubMed ID: 12882687 [TBL] [Abstract][Full Text] [Related]
37. Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry. Kanter-Lewensohn L; Hellström-Lindberg E; Kock Y; Elmhorn-Rosenborg A; Ost A Eur J Haematol; 1996 Mar; 56(3):124-9. PubMed ID: 8598230 [TBL] [Abstract][Full Text] [Related]
38. Cell proliferation in human tumour xenografts: measurement using antibody labelling against bromodeoxyuridine and Ki-67. Parkins CS; Bush C; Price P; Steel GG Cell Prolif; 1991 Mar; 24(2):171-9. PubMed ID: 2009320 [TBL] [Abstract][Full Text] [Related]
39. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes]. Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Wu YH; Jing LP; He GS; Cao YR; Wang XL; Tu MF; Hao YS; Yang TY Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):641-4. PubMed ID: 15634564 [TBL] [Abstract][Full Text] [Related]
40. AIDS-related bone marrow lesions--myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling. Thiele J; Zirbes TK; Bertsch HP; Titius BR; Lorenzen J; Fischer R Anal Cell Pathol; 1996 Aug; 11(3):141-57. PubMed ID: 8888951 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]